Psychedelics and Autism
The conversation delves into the potential of psychedelics to enhance metaplasticity, particularly in relation to autism and fragile X syndrome. There’s a discussion about the role of metabotropic glutamate receptors and the hypothesis that autism may stem from a failure to close critical developmental periods. While the idea of combining psychedelics with specific modulators is intriguing, caution is advised regarding human trials without prior safety testing in animal models.In this clip
From this podcast
Tim Ferriss Show
Rethinking Psychedelics, Octopuses on MDMA, and The Master Key of Metaplasticity | Dr. Gül Dölen
Related Questions
Explain the neuroscience of psychedelics, especially with a focus on neuroplasticity, as discussed in the episode Rethinking Psychedelics, Octopuses on MDMA, and The Master Key of Metaplasticity | Dr. Gül Dölen and the clip Psychedelic Mechanisms
Is there any research related to critical periods and psychedelics?
What research supports psychedelic therapy in the context of the episodes Rethinking Psychedelics, Octopuses on MDMA, and The Master Key of Metaplasticity | Dr. Gül Dölen and Future of Psychedelic Therapy?